BELDIN Drug Patent Profile
✉ Email this page to a colleague
When do Beldin patents expire, and when can generic versions of Beldin launch?
Beldin is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in BELDIN is diphenhydramine hydrochloride. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Beldin
A generic version of BELDIN was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BELDIN?
- What are the global sales for BELDIN?
- What is Average Wholesale Price for BELDIN?
Summary for BELDIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 115 |
| Patent Applications: | 2,411 |
| DailyMed Link: | BELDIN at DailyMed |
US Patents and Regulatory Information for BELDIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halsey | BELDIN | diphenhydramine hydrochloride | SYRUP;ORAL | 089179-001 | Jun 5, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
